Monitoring how T cells respond to HIV
Inside these squares, single T cells taken from HIV-infected patients interact with infected cells. This technology, developed by MIT chemical engineers, offers the first way to study how effectively individual T cells respond to HIV-infected cells. Image: Navin Varadarajan
One of the obstacles to developing an effective AIDS vaccine is the difficulty in measuring how well a potential vaccine primes the body to defend itself against HIV.
Ideally, scientists would like their vaccines to provoke T cells, a critical component of the immune response, to recognize and kill HIV-infected cells. Unfortunately, there is no fast and easy way to monitor whether T cells are actually doing that. Instead, researchers measure the amount of a protein called interferon gamma that T cells secrete when they encounter an infected cell. Studies have shown, however, that this surrogate measurement doesnt necessarily predict a T cells ability to kill HIV-infected cells.
In an advance that could overcome that obstacle, a team of researchers at MIT has developed a new technology that can measure multiple aspects of individual T cells responses to HIV-infected cells, including their ability to kill them. The technology could make it easier to monitor and design vaccines against HIV, says J. Christopher Love, the Latham Family Career Development Associate Professor of Chemical Engineering and leader of the research team.
The technology, described in a paper published in the Oct. 3 online edition of the Journal of Clinical Investigation, involves two steps. First, the researchers place single T cells taken from HIV-infected patients into tiny wells on a plate, where they are exposed to HIV-infected cells. The researchers can detect whether the T cells kill the infected cells with probes that glow when the dying cells nuclei become compromised.
Watch T cells attack HIV-infected cells:
This video is not supported by your browser at this time.Next, the researchers measure interferon gamma production with a microengraving technique they developed in 2008. Secretions from each cell are imprinted on a glass slide, which can then be tested for the presence of specific proteins. Because each cell has its own address on the slide, the secretions can be traced back to individual cells, and their interferon gamma production can be correlated directly to their cell-killing ability.
The same technology could be adapted to measure cells output of any other immune system protein.
In this study, the researchers found that while the percentage of T cells that secrete interferon gamma is similar to the percentage of those that kill infected cells, the populations are not identical. In future studies, the researchers hope to find markers that do correlate with cell-killing ability, making it easier to evaluate a potential vaccines effectiveness.
Now that we have a tool to look directly at a variety of different functional activities, you can go in and start to evaluate other markers that may be better predictors of killing. Those then become what you would want to monitor in vaccine trials, says Love, who is also a member of the Ragon Institute of MGH, MIT and Harvard and the David H. Koch Institute for Integrative Cancer Research at MIT.
The appeal of this technology is that it can help us understand more about whats going on in single cells, says Alan Landay, professor of immunology and microbiology at Rush Medical College. It helps us rethink what we understand about immunology and immune function.
More research will be needed to develop the technology to the point where it can be used routinely in vaccine trials for large-scale studies of patient samples.
This story is republished courtesy of MIT News (web.mit.edu/newsoffice/), a popular site that covers news about MIT research, innovation and teaching.
Provided by Massachusetts Institute of Technology
- Well-armed immune cells help long-term non-progressors contain HIV Dec 04, 2008 | not rated yet | 0
- Nano-sized vaccines Feb 22, 2011 | not rated yet | 0
- Extraordinary immune cells may hold the key to managing HIV Dec 04, 2008 | not rated yet | 0
- Elite controllers block integration of HIV DNA into host genome Sep 19, 2011 | not rated yet | 0
- Exhausted B cells hamper immune response to HIV Jul 14, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
HIV & AIDS 2 hours ago | not rated yet | 0
Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...
HIV & AIDS 16 hours ago | not rated yet | 0
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
HIV & AIDS 16 hours ago | not rated yet | 0
A new Yale study looks at the scope and consequences of a burgeoning health problem in the cities of the U.S. Northeast: concurrent infection with both HIV and Hepatitis C (HCV). The study appears online ...
HIV & AIDS 20 hours ago | not rated yet | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
3 hours ago | not rated yet | 0 |
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
13 hours ago | not rated yet | 0 |
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
14 hours ago | 3.7 / 5 (3) | 0 |
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
11 hours ago | 3.7 / 5 (3) | 0 |
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
11 hours ago | 5 / 5 (2) | 0 |
In order to avoid harms associated with alcohol consumption, in 2009 the National Institute on Alcohol Abuse and Alcoholism issued guidelines that define low-risk drinking. These guidelines differ for men and women: no more ...
11 hours ago | not rated yet | 0 |